ZAMPIERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.907
NA - Nord America 2.855
EU - Europa 2.390
SA - Sud America 277
AF - Africa 55
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.788
RU - Federazione Russa 1.043
SG - Singapore 918
CN - Cina 874
IT - Italia 547
HK - Hong Kong 295
KR - Corea 258
VN - Vietnam 217
BR - Brasile 205
FI - Finlandia 132
IE - Irlanda 129
DE - Germania 121
GB - Regno Unito 87
FR - Francia 84
SE - Svezia 83
IN - India 81
BD - Bangladesh 60
TR - Turchia 58
AU - Australia 37
AR - Argentina 36
JO - Giordania 33
ID - Indonesia 32
JP - Giappone 30
CA - Canada 28
MX - Messico 27
ES - Italia 25
NL - Olanda 25
CH - Svizzera 21
DK - Danimarca 18
PL - Polonia 16
EG - Egitto 15
EC - Ecuador 12
IQ - Iraq 12
NG - Nigeria 11
UA - Ucraina 9
GR - Grecia 8
ZA - Sudafrica 8
CL - Cile 7
BE - Belgio 6
CZ - Repubblica Ceca 6
MA - Marocco 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BJ - Benin 5
NO - Norvegia 5
RS - Serbia 5
VE - Venezuela 5
AL - Albania 4
PK - Pakistan 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
KE - Kenya 3
MY - Malesia 3
UZ - Uzbekistan 3
BH - Bahrain 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
ZM - Zambia 1
Totale 8.522
Salva come PNG Salva come JPEG
Città #
Santa Clara 877
Singapore 682
Ashburn 452
Hefei 317
Hong Kong 263
Seoul 258
San Jose 185
Dublin 127
Milan 104
Helsinki 90
Beijing 83
Los Angeles 78
Council Bluffs 77
Ho Chi Minh City 77
Florence 58
Munich 58
Chandler 56
New York 56
Moscow 51
Hanoi 50
Kent 42
Rome 42
The Dalles 42
Lauterbourg 41
Fairfield 37
Buffalo 36
Melbourne 36
Dallas 34
Shanghai 31
Istanbul 29
Jakarta 28
Tokyo 27
Seattle 26
Altamura 23
Lawrence 23
Mumbai 23
Houston 22
Frankfurt am Main 21
Turku 21
London 20
Bengaluru 19
Lappeenranta 19
Copenhagen 18
Ann Arbor 17
Woodbridge 17
Bern 16
Boston 16
Naples 16
Cambridge 15
Orem 15
Phoenix 14
Princeton 14
São Paulo 14
West Jordan 14
Chennai 12
Chicago 12
Abuja 11
Adapazarı 11
Düsseldorf 11
Figino 11
Mudanya 11
Prato 11
Da Nang 10
Warsaw 10
Yubileyny 10
Paris 9
San Francisco 9
Toronto 9
Amsterdam 8
Hillsboro 8
Manchester 8
Pune 8
Atlanta 7
Bologna 7
Madrid 7
Medford 7
Palermo 7
Poplar 7
Rio de Janeiro 7
San Diego 7
Stockholm 7
Wilmington 7
Asyut 6
Biên Hòa 6
Boardman 6
Johannesburg 6
Mexico City 6
Miano 6
Montreal 6
Nuremberg 6
Pisa 6
Turin 6
Athens 5
Baghdad 5
Bayreuth 5
Belgrade 5
Brussels 5
Buenos Aires 5
Changsha 5
City of London 5
Totale 5.176
Salva come PNG Salva come JPEG
Nome #
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 253
Standard Therapy in Cardiac Amyloidosis 211
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 209
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 202
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 201
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 199
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 196
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 193
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 190
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 187
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 183
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 177
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 169
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 169
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 167
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 166
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 165
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 164
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 164
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 163
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 162
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 161
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 160
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series 159
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 157
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis 157
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study 156
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 156
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 156
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 154
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 154
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 153
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 152
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 151
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 149
Prevalence of carpal tunnel syndrome in patients with transthyretin cardiac amyloidosis 147
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 147
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 146
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery 144
Stage-specific therapy for hypertrophic cardiomyopathy 143
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 142
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 141
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 139
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 139
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 139
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 133
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 132
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 127
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 119
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 114
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 114
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition 84
Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation 61
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-study 54
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis 49
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data 46
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 31
Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63 19
Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options 18
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis 15
Totale 8.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022130 8 4 5 9 4 10 6 6 16 12 19 31
2022/2023543 22 75 15 16 55 81 102 34 58 18 28 39
2023/2024548 30 39 46 30 36 68 33 132 12 54 32 36
2024/20253.015 86 282 161 485 759 378 87 151 148 74 169 235
2025/20264.210 400 551 573 388 405 149 452 225 332 296 151 288
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 8.608